Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1989 Dec 1;170(6):1999–2010. doi: 10.1084/jem.170.6.1999

Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis

PMCID: PMC2189520  PMID: 2479704

Abstract

We have previously reported that collagen-induced arthritis can be suppressed by intravenous injection of native type II (CII) but not type I collagen. We have now identified denatured fragments of CII capable of suppressing collagen-induced arthritis and inducing tolerance. Purified CII was cleaved with cyanogen bromide (CB), and the major resulting peptides were isolated. Female DBA/1 mice were administered OVA, native CII, or one of the CB peptides, intravenously, before immunization with native CII, 6 wk after immunization, mice tolerized with CII and CB11 had a markedly lower incidence of arthritis compared with controls. There was a correlation between the overall antibody response and the incidence of arthritis. In addition, animals tolerized with either CII or CB11 had a decreased antibody response not only to CII, but also to each of the other CB peptides tested. To identify the epitope involved in suppression of arthritis, five synthetic peptides, 21-26 amino acids in length, corresponding to selected regions of CB11, were generated. Each of the peptides was injected intravenously into mice before immunization. Only one of these, CB11 122-147, was capable of suppressing arthritis. In addition, mice given the synthetic peptide CB11 122-147 neonatally were suppressed for arthritis and antibody responsiveness when immunized with CII at 8 wk of age. Thus, we have identified CB11 122-147 as an epitope of CII important in induction of tolerance and suppression of disease. Further experiments narrowing down the pivotal amino acids for the immunogenicity of this epitope and the role this epitope plays in induction and regulation of disease will enhance our understanding of how the immune response to collagen affects autoimmune arthritis.

Full Text

The Full Text of this article is available as a PDF (767.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adorini L., Harvey M. A., Miller A., Sercarz E. E. Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med. 1979 Aug 1;150(2):293–306. doi: 10.1084/jem.150.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andriopoulos N. A., Mestecky J., Miller E. J., Bradley E. L. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 1976 May-Jun;19(3):613–617. doi: 10.1002/art.1780190314. [DOI] [PubMed] [Google Scholar]
  3. Arai K., Kaibara N., Takagishi K., Hotokebuchi T., Arita C. Reversal of antigen-induced resistance to collagen arthritis by cyclophosphamide. Clin Immunol Immunopathol. 1987 Jun;43(3):325–332. doi: 10.1016/0090-1229(87)90142-5. [DOI] [PubMed] [Google Scholar]
  4. Berzofsky J. A. Immunodominance in T lymphocyte recognition. Immunol Lett. 1988 Jun;18(2):83–92. doi: 10.1016/0165-2478(88)90046-6. [DOI] [PubMed] [Google Scholar]
  5. Brahn E., Trentham D. E. Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells. Clin Immunol Immunopathol. 1984 Apr;31(1):124–131. doi: 10.1016/0090-1229(84)90197-1. [DOI] [PubMed] [Google Scholar]
  6. Burrai I., Henderson B., Knight S. C., Staines N. A. Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clin Exp Immunol. 1985 Aug;61(2):368–372. [PMC free article] [PubMed] [Google Scholar]
  7. Chou C. H., Chou F. C., Kowalski T. J., Shapira R., Kibler R. F. The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats. J Neurochem. 1977 Jan;28(1):115–119. doi: 10.1111/j.1471-4159.1977.tb07716.x. [DOI] [PubMed] [Google Scholar]
  8. Clayton J. P., Gammon G. M., Ando D. G., Kono D. H., Hood L., Sercarz E. E. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med. 1989 May 1;169(5):1681–1691. doi: 10.1084/jem.169.5.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cremer M. A., Hernandez A. D., Townes A. S., Stuart J. M., Kang A. H. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol. 1983 Dec;131(6):2995–3000. [PubMed] [Google Scholar]
  10. Englert M. E., Landes M. J., Oronsky A. L., Kerwar S. S. Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide alpha 1 (II) CB10. Cell Immunol. 1984 Sep;87(2):357–365. doi: 10.1016/0008-8749(84)90005-4. [DOI] [PubMed] [Google Scholar]
  11. Gammon G. M., Oki A., Shastri N., Sercarz E. E. Induction of tolerance to one determinant on a synthetic peptide does not affect the response to a second linked determinant. Implications for the mechanism of neonatal tolerance induction. J Exp Med. 1986 Aug 1;164(2):667–672. doi: 10.1084/jem.164.2.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gammon G., Dunn K., Shastri N., Oki A., Wilbur S., Sercarz E. E. Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. 1986 Jan 30-Feb 5Nature. 319(6052):413–415. doi: 10.1038/319413a0. [DOI] [PubMed] [Google Scholar]
  13. Guillet J. G., Lai M. Z., Briner T. J., Buus S., Sette A., Grey H. M., Smith J. A., Gefter M. L. Immunological self, nonself discrimination. Science. 1987 Feb 20;235(4791):865–870. doi: 10.1126/science.2433769. [DOI] [PubMed] [Google Scholar]
  14. Jenkins M. K., Schwartz R. H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987 Feb 1;165(2):302–319. doi: 10.1084/jem.165.2.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jensen P. E., Pierce C. W., Kapp J. A. Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med. 1984 Oct 1;160(4):1012–1026. doi: 10.1084/jem.160.4.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Konomi H., Seyer J. M., Ninomiya Y., Olsen B. R. Peptide-specific antibodies identify the alpha 2 chain as the proteoglycan subunit of type IX collagen. J Biol Chem. 1986 May 25;261(15):6742–6746. [PubMed] [Google Scholar]
  17. Kresina T. F. Down-regulation of murine collagen-induced arthritis by a T cell hybridoma. Exp Cell Biol. 1988;56(1-2):86–102. doi: 10.1159/000163466. [DOI] [PubMed] [Google Scholar]
  18. Kresina T. F., Moskowitz R. W. Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell. J Clin Invest. 1985 Jun;75(6):1990–1998. doi: 10.1172/JCI111917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lanzavecchia A. Is suppression a function of class II--restricted cytotoxic T cells? Immunol Today. 1989 May;10(5):157–159. doi: 10.1016/0167-5699(89)90172-2. [DOI] [PubMed] [Google Scholar]
  20. Mikecz K., Glant T. T., Poole A. R. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 1987 Mar;30(3):306–318. doi: 10.1002/art.1780300310. [DOI] [PubMed] [Google Scholar]
  21. Miller E. J. Isolation and characterization of the cyanogen bromide peptides from the l(II) chain of chick cartilage collagen. Biochemistry. 1971 Aug 3;10(16):3030–3035. doi: 10.1021/bi00792a007. [DOI] [PubMed] [Google Scholar]
  22. Muckerheide A., Pesce A. J., Michael J. G. Immunosuppressive properties of a peptic fragment of BSA. J Immunol. 1977 Oct;119(4):1340–1345. [PubMed] [Google Scholar]
  23. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443–7446. doi: 10.1073/pnas.83.19.7443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Oki A., Sercarz E. T cell tolerance studied at the level of antigenic determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice. J Exp Med. 1985 May 1;161(5):897–911. doi: 10.1084/jem.161.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schoen R. T., Greene M. I., Trentham D. E. Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells. J Immunol. 1982 Feb;128(2):717–719. [PubMed] [Google Scholar]
  26. Sette A., Buus S., Colon S., Smith J. A., Miles C., Grey H. M. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. 1987 Jul 30-Aug 5Nature. 328(6129):395–399. doi: 10.1038/328395a0. [DOI] [PubMed] [Google Scholar]
  27. Stuart J. M., Cremer M. A., Kang A. H., Townes A. S. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum. 1979 Dec;22(12):1344–1351. doi: 10.1002/art.1780221205. [DOI] [PubMed] [Google Scholar]
  28. Stuart J. M., Townes A. S., Kang A. H. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest. 1982 Mar;69(3):673–683. doi: 10.1172/JCI110495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Swanborg R. H. Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. J Immunol. 1975 Jan;114(1 Pt 1):191–194. [PubMed] [Google Scholar]
  30. Terato K., Cremer M. A., Hasty K. A., Kang A. H., Hasty D. L., Townes A. S. Physicochemical and immunological studies of the renatured alpha 1(II) chains and isolated cyanogen bromide peptides of type II collagen. Coll Relat Res. 1985 Dec;5(6):469–480. doi: 10.1016/s0174-173x(85)80001-7. [DOI] [PubMed] [Google Scholar]
  31. Terato K., Hasty K. A., Cremer M. A., Stuart J. M., Townes A. S., Kang A. H. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med. 1985 Aug 1;162(2):637–646. doi: 10.1084/jem.162.2.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Turkin D., Sercarz E. E. Key antigenic determinants in regulation of the immune response. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3984–3987. doi: 10.1073/pnas.74.9.3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Unanue E. R., Allen P. M. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987 May 1;236(4801):551–557. doi: 10.1126/science.2437650. [DOI] [PubMed] [Google Scholar]
  35. Witter J., Roughley P. J., Webber C., Roberts N., Keystone E., Poole A. R. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum. 1987 May;30(5):519–529. doi: 10.1002/art.1780300506. [DOI] [PubMed] [Google Scholar]
  36. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zvaifler N. J. Pathogenesis of the joint disease of rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):3–8. doi: 10.1016/0002-9343(83)90469-2. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES